Latest Daiichi Sankyo Stories
MUNICH, Germany, April 2, 2014 /PRNewswire/ -- For European Media Only, Not for UK Media Atrial fibrillation (AF) is the most common heart rhythm
First patient enrolled in largest planned phase 3 study evaluating a novel oral anticoagulant in non-valvular atrial fibrillation patients undergoing electrical cardioversion PARSIPPANY, N.J.,
DUBLIN, March 28, 2014 /PRNewswire/ -- Dublin - Research and Markets ( http://www.researchandmarkets.com/research/3vpmvj/investigation) has announced the addition of the
Pharmica Consulting, the industry leader in life science processes and technology, is pleased to announce that Teresa Faria and James McGurk of Daiichi Sankyo will speak at Pharmica’s SharePoint
TOKYO, March 19, 2014 /PRNewswire/ -- Astellas Pharma Inc.
DUBLIN, March 5, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/w2749d/antibody_drug) has announced the addition of the "Antibody
Pharmacist Partners is pleased to announce its participation in PanAgora Pharma's upcoming Customer Experience Summit March 5-6, 2014 in Princeton, NJ. NEW YORK, Feb.
MUMBAI, India, February 11, 2014 /PRNewswire/ -- Bharat Book Bureau presents Global Pharmaceutical & Biotechnology Outlook 2014: Japan Pharma.